论文部分内容阅读
我院观察了40例终末期肾病并尿毒症病人应用1α羟基维生素Ｄ3(以下简称阿法骨化醇)前后血清钙磷及碱性磷酸酶、骨密度的变化。结果表明阿法骨化醇确能纠正病人的低钙高磷血症,部分改善病人的临床症状和骨密度,使骨密度下降改善。1 对象与方法11 对象 选择我科1997年5月～199
Our hospital observed 40 cases of end-stage renal disease and uremia in patients with 1α hydroxy vitamin D3 (hereinafter referred to alfacalciferol) before and after serum calcium and phosphorus and alkaline phosphatase, bone mineral density changes. The results showed that alfacalcidol did correct the patients with hypocalcemia and partially improved the patient’s clinical symptoms and bone mineral density, thus reducing and improving the bone mineral density. 1 objects and methods 11 object selection our department May 1997 ~ 199